FGFR3 and achondroplasia: They have also demonstrated a decrease in the protein levels of FGFR3 in the patient-derived induced pluripotent stem cells (iPSCs) differentiated into the chondrogenic lineage and in the Fgfr3Ach mouse model of ACH.